Preston IR - Search Results

1

Effects of sotatercept on haemodynamics and right heart function: analysis of the STELLAR trial.

Souza R, Badesch DB, Ghofrani HA, Gibbs JSR, Gomberg-Maitland M, McLaughlin VV, Preston IR, Waxman AB, Grünig E, Kopeć G, Meyer G, Olsson KM, Rosenkranz S, Lin J, Johnson-Levonas AO, de Oliveira Pena J, Humbert M, Hoeper MM. Souza R, et al. Among authors: preston ir. Eur Respir J. 2023 Sep 21;62(3):2301107. doi: 10.1183/13993003.01107-2023. Print 2023 Sep. Eur Respir J. 2023. PMID: 37696565 Free PMC article.

2

Clinical perspective of hypoxia-mediated pulmonary hypertension.

Preston IR. Preston IR. Antioxid Redox Signal. 2007 Jun;9(6):711-21. doi: 10.1089/ars.2007.1587. Antioxid Redox Signal. 2007. PMID: 17511586 Review.

3

[Current treatment of pulmonary arterial hypertension].

Preston IR. Preston IR. Zhonghua Yi Xue Za Zhi. 2009 Aug 11;89(30):2095-6. Zhonghua Yi Xue Za Zhi. 2009. PMID: 20058609 Chinese. No abstract available.

4

Casting light on overlapping symptoms. Sarcoidosis.

Preston I, O'Brien A. Preston I, et al. Postgrad Med. 2002 May;111(5):81-4. doi: 10.3810/pgm.2002.05.1214. Postgrad Med. 2002. PMID: 12040865 No abstract available.

5

Role of 12-lipoxygenase in hypoxia-induced rat pulmonary artery smooth muscle cell proliferation.

Preston IR, Hill NS, Warburton RR, Fanburg BL. Preston IR, et al. Am J Physiol Lung Cell Mol Physiol. 2006 Feb;290(2):L367-74. doi: 10.1152/ajplung.00114.2005. Epub 2005 Sep 30. Am J Physiol Lung Cell Mol Physiol. 2006. PMID: 16199435 Free article.

6

Retinoids and pulmonary hypertension.

Preston IR, Tang G, Tilan JU, Hill NS, Suzuki YJ. Preston IR, et al. Circulation. 2005 Feb 15;111(6):782-90. doi: 10.1161/01.CIR.0000155254.86840.47. Epub 2005 Feb 7. Circulation. 2005. PMID: 15699255

7

Pulmonary edema caused by inhaled nitric oxide therapy in two patients with pulmonary hypertension associated with the CREST syndrome.

Preston IR, Klinger JR, Houtchens J, Nelson D, Mehta S, Hill NS. Preston IR, et al. Chest. 2002 Feb;121(2):656-9. doi: 10.1378/chest.121.2.656. Chest. 2002. PMID: 11834688

8

Pulmonary hypertension: inhaled nitric oxide, sildenafil and natriuretic peptides.

Steiner MK, Preston IR, Klinger JR, Hill NS. Steiner MK, et al. Among authors: preston ir. Curr Opin Pharmacol. 2005 Jun;5(3):245-50. doi: 10.1016/j.coph.2004.12.008. Curr Opin Pharmacol. 2005. PMID: 15907910 Review.

9

Prostacyclin therapy for pulmonary arterial hypertension: new directions.

Gomberg-Maitland M, Preston IR. Gomberg-Maitland M, et al. Among authors: preston ir. Semin Respir Crit Care Med. 2005 Aug;26(4):394-401. doi: 10.1055/s-2005-916154. Semin Respir Crit Care Med. 2005. PMID: 16121316 Review.

10

Conversion to bosentan from prostacyclin infusion therapy in pulmonary arterial hypertension: a pilot study.

Steiner MK, Preston IR, Klinger JR, Criner GJ, Waxman AB, Farber HW, Hill NS. Steiner MK, et al. Among authors: preston ir. Chest. 2006 Nov;130(5):1471-80. doi: 10.1378/chest.130.5.1471. Chest. 2006. PMID: 17099026 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

89 results

Search Page